PRESS RELEASE published on 09/03/2024 at 10:15, 2 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Press release regarding the declaration of the number of shares and voting rights at Sartorius Stedim Biotech S.A. in France Voting Rights Déclaration Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 09/03/2024 at 10:15, 2 years 1 month ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in the issued capital. Total shares: 97,330,405. Total voting rights: 165,568,221 Voting Rights Shares Sartorius Stedim Biotech Issued Capital Announcement
BRIEF published on 08/02/2024 at 12:27, 2 years 2 months ago Sartorius Stedim Biotech Announces Share and Voting Rights Update Voting Rights Shares Regulatory Compliance Sartorius Stedim Biotech Issued Capital
PRESS RELEASE published on 08/02/2024 at 12:23, 2 years 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the total number of shares and voting rights, as of July 31, 2024, in compliance with legal requirements Voting Rights Déclaration Shares Sartorius Stedim Biotech SA July 31 2024
PRESS RELEASE published on 08/02/2024 at 12:22, 2 years 2 months ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights in their issued capital. Details in the announcement Voting Rights Shares AMF Sartorius Stedim Biotech SA French Regulatory News
BRIEF published on 07/19/2024 at 09:55, 2 years 3 months ago Sartorius Stedim Biotech SA: Provision of financial documents Financial Results Investors Sartorius Stedim Biotech First Half Of 2024 Documents Available
PRESS RELEASE published on 07/19/2024 at 09:51, 2 years 3 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech Group releases first-half 2024 results report with business development and financial statements. Leading biopharmaceutical partner based in Aubagne, France Financial Statements Biopharmaceutical Industry Sartorius Stedim Biotech Group First-half 2024 Results Aubagne
PRESS RELEASE published on 07/19/2024 at 09:50, 2 years 3 months ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases information on the availability of documents, including first half 2024 results and financial statements Financial Results Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry Document Availability
PRESS RELEASE published on 07/19/2024 at 09:37, 2 years 3 months ago Half yearly financial reports and audit reports/limited reviews
PRESS RELEASE published on 07/18/2024 at 18:30, 2 years 3 months ago Half-year results 2024 of SartoriusStedimBiotech Sartorius Stedim Biotech reports half-year results for 2024 with sales revenue of 1,373 million euros and a cautious outlook for the year ahead due to market volatility Volatility Sartorius Stedim Biotech Sales Revenue Outlook Half-year Results
Published on 10/30/2026 at 23:35, 1 day 3 hours ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 3 hours ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 7 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 11 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 10 hours 15 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 4 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 8 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 3 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 14 hours ago Capital increase through exercise of subscription rights
